BIOMAT Database Logo BIOMAT Database Logo

[Physiopathology of human pancreatic polypeptide (hPP)]. 1986

R Lugari, and P Dall'Argine, and A Parmeggiani, and A Vattini, and B Dall'Aglio, and G Rignanese, and R Zandomeneghi, and A Gnudi

UI MeSH Term Description Entries
D007328 Insulin A 51-amino acid pancreatic hormone that plays a major role in the regulation of glucose metabolism, directly by suppressing endogenous glucose production (GLYCOGENOLYSIS; GLUCONEOGENESIS) and indirectly by suppressing GLUCAGON secretion and LIPOLYSIS. Native insulin is a globular protein comprised of a zinc-coordinated hexamer. Each insulin monomer containing two chains, A (21 residues) and B (30 residues), linked by two disulfide bonds. Insulin is used as a drug to control insulin-dependent diabetes mellitus (DIABETES MELLITUS, TYPE 1). Iletin,Insulin A Chain,Insulin B Chain,Insulin, Regular,Novolin,Sodium Insulin,Soluble Insulin,Chain, Insulin B,Insulin, Sodium,Insulin, Soluble,Regular Insulin
D007668 Kidney Body organ that filters blood for the secretion of URINE and that regulates ion concentrations. Kidneys
D009765 Obesity A status with BODY WEIGHT that is grossly above the recommended standards, usually due to accumulation of excess FATS in the body. The standards may vary with age, sex, genetic or cultural background. In the BODY MASS INDEX, a BMI greater than 30.0 kg/m2 is considered obese, and a BMI greater than 40.0 kg/m2 is considered morbidly obese (MORBID OBESITY).
D010179 Pancreas A nodular organ in the ABDOMEN that contains a mixture of ENDOCRINE GLANDS and EXOCRINE GLANDS. The small endocrine portion consists of the ISLETS OF LANGERHANS secreting a number of hormones into the blood stream. The large exocrine portion (EXOCRINE PANCREAS) is a compound acinar gland that secretes several digestive enzymes into the pancreatic ductal system that empties into the DUODENUM.
D010191 Pancreatic Polypeptide A 36-amino acid pancreatic hormone that is secreted mainly by endocrine cells found at the periphery of the ISLETS OF LANGERHANS and adjacent to cells containing SOMATOSTATIN and GLUCAGON. Pancreatic polypeptide (PP), when administered peripherally, can suppress gastric secretion, gastric emptying, pancreatic enzyme secretion, and appetite. A lack of pancreatic polypeptide (PP) has been associated with OBESITY in rats and mice. Pancreatic Polypeptide (PP),Pancreatic Polypeptide Hormone,Pancreatic Prohormone
D003389 Cranial Nerve Diseases Disorders of one or more of the twelve cranial nerves. With the exception of the optic and olfactory nerves, this includes disorders of the brain stem nuclei from which the cranial nerves originate or terminate. Cranial Neuropathies,Cranial Neuropathies, Multiple,Neuropathies, Cranial,Cranial Nerve Disorders,Cranial Nerve Palsies,Nervus Cranialis Disorders,Cranial Nerve Disease,Cranial Nerve Disorder,Cranial Nerve Palsy,Cranial Neuropathy,Cranial Neuropathy, Multiple,Multiple Cranial Neuropathies,Multiple Cranial Neuropathy,Nervus Cranialis Disorder,Neuropathies, Multiple Cranial,Neuropathy, Cranial,Neuropathy, Multiple Cranial,Palsies, Cranial Nerve,Palsy, Cranial Nerve
D003922 Diabetes Mellitus, Type 1 A subtype of DIABETES MELLITUS that is characterized by INSULIN deficiency. It is manifested by the sudden onset of severe HYPERGLYCEMIA, rapid progression to DIABETIC KETOACIDOSIS, and DEATH unless treated with insulin. The disease may occur at any age, but is most common in childhood or adolescence. Diabetes Mellitus, Brittle,Diabetes Mellitus, Insulin-Dependent,Diabetes Mellitus, Juvenile-Onset,Diabetes Mellitus, Ketosis-Prone,Diabetes Mellitus, Sudden-Onset,Diabetes, Autoimmune,IDDM,Autoimmune Diabetes,Diabetes Mellitus, Insulin-Dependent, 1,Diabetes Mellitus, Type I,Insulin-Dependent Diabetes Mellitus 1,Juvenile-Onset Diabetes,Type 1 Diabetes,Type 1 Diabetes Mellitus,Brittle Diabetes Mellitus,Diabetes Mellitus, Insulin Dependent,Diabetes Mellitus, Juvenile Onset,Diabetes Mellitus, Ketosis Prone,Diabetes Mellitus, Sudden Onset,Diabetes, Juvenile-Onset,Diabetes, Type 1,Insulin Dependent Diabetes Mellitus 1,Insulin-Dependent Diabetes Mellitus,Juvenile Onset Diabetes,Juvenile-Onset Diabetes Mellitus,Ketosis-Prone Diabetes Mellitus,Sudden-Onset Diabetes Mellitus
D003929 Diabetic Neuropathies Peripheral, autonomic, and cranial nerve disorders that are associated with DIABETES MELLITUS. These conditions usually result from diabetic microvascular injury involving small blood vessels that supply nerves (VASA NERVORUM). Relatively common conditions which may be associated with diabetic neuropathy include third nerve palsy (see OCULOMOTOR NERVE DISEASES); MONONEUROPATHY; mononeuropathy multiplex; diabetic amyotrophy; a painful POLYNEUROPATHY; autonomic neuropathy; and thoracoabdominal neuropathy. (From Adams et al., Principles of Neurology, 6th ed, p1325) Diabetic Amyotrophy,Diabetic Autonomic Neuropathy,Diabetic Neuralgia,Diabetic Polyneuropathy,Neuralgia, Diabetic,Asymmetric Diabetic Proximal Motor Neuropathy,Diabetic Asymmetric Polyneuropathy,Diabetic Mononeuropathy,Diabetic Mononeuropathy Simplex,Diabetic Neuropathy, Painful,Mononeuropathy, Diabetic,Symmetric Diabetic Proximal Motor Neuropathy,Amyotrophies, Diabetic,Amyotrophy, Diabetic,Asymmetric Polyneuropathies, Diabetic,Asymmetric Polyneuropathy, Diabetic,Autonomic Neuropathies, Diabetic,Autonomic Neuropathy, Diabetic,Diabetic Amyotrophies,Diabetic Asymmetric Polyneuropathies,Diabetic Autonomic Neuropathies,Diabetic Mononeuropathies,Diabetic Mononeuropathy Simplices,Diabetic Neuralgias,Diabetic Neuropathies, Painful,Diabetic Neuropathy,Diabetic Polyneuropathies,Mononeuropathies, Diabetic,Mononeuropathy Simplex, Diabetic,Mononeuropathy Simplices, Diabetic,Neuralgias, Diabetic,Neuropathies, Diabetic,Neuropathies, Diabetic Autonomic,Neuropathies, Painful Diabetic,Neuropathy, Diabetic,Neuropathy, Diabetic Autonomic,Neuropathy, Painful Diabetic,Painful Diabetic Neuropathies,Painful Diabetic Neuropathy,Polyneuropathies, Diabetic,Polyneuropathies, Diabetic Asymmetric,Polyneuropathy, Diabetic,Polyneuropathy, Diabetic Asymmetric,Simplex, Diabetic Mononeuropathy,Simplices, Diabetic Mononeuropathy
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000078790 Insulin Secretion Production and release of insulin from PANCREATIC BETA CELLS that primarily occurs in response to elevated BLOOD GLUCOSE levels. Secretion, Insulin

Related Publications

R Lugari, and P Dall'Argine, and A Parmeggiani, and A Vattini, and B Dall'Aglio, and G Rignanese, and R Zandomeneghi, and A Gnudi
[Human pancreatic polypeptide (hPP)].
March 1995, Nihon rinsho. Japanese journal of clinical medicine,
R Lugari, and P Dall'Argine, and A Parmeggiani, and A Vattini, and B Dall'Aglio, and G Rignanese, and R Zandomeneghi, and A Gnudi
[Human pancreatic polypeptide (hPP)].
December 1999, Nihon rinsho. Japanese journal of clinical medicine,
R Lugari, and P Dall'Argine, and A Parmeggiani, and A Vattini, and B Dall'Aglio, and G Rignanese, and R Zandomeneghi, and A Gnudi
Adrenergic modulation of human pancreatic polypeptide (hPP) release.
October 1980, Gastroenterology,
R Lugari, and P Dall'Argine, and A Parmeggiani, and A Vattini, and B Dall'Aglio, and G Rignanese, and R Zandomeneghi, and A Gnudi
Immunohistochemical localization of human pancreatic polypeptide (HPP) in the human endocrine pancreas.
March 1977, Gastroenterology,
R Lugari, and P Dall'Argine, and A Parmeggiani, and A Vattini, and B Dall'Aglio, and G Rignanese, and R Zandomeneghi, and A Gnudi
Motilin, human pancreatic polypeptide (HPP) and gastrin plasma concentrations in fasting subjects.
August 1979, Clinical biochemistry,
R Lugari, and P Dall'Argine, and A Parmeggiani, and A Vattini, and B Dall'Aglio, and G Rignanese, and R Zandomeneghi, and A Gnudi
Immunohistochemical localization of human pancreatic polypeptide (HPP) to a population of islet cells.
January 1975, Cell and tissue research,
R Lugari, and P Dall'Argine, and A Parmeggiani, and A Vattini, and B Dall'Aglio, and G Rignanese, and R Zandomeneghi, and A Gnudi
Identification of the D1-cell as the source of human pancreatic polypeptide (HPP).
October 1976, Gut,
R Lugari, and P Dall'Argine, and A Parmeggiani, and A Vattini, and B Dall'Aglio, and G Rignanese, and R Zandomeneghi, and A Gnudi
Effect of human pancreatic polypeptide (HPP) on the release of anterior pituitary hormones.
January 1986, Acta physiologica Hungarica,
R Lugari, and P Dall'Argine, and A Parmeggiani, and A Vattini, and B Dall'Aglio, and G Rignanese, and R Zandomeneghi, and A Gnudi
Cellular origin of human pancreatic polypeptide (HPP) in endocrine tumours of the pancreas.
September 1976, Virchows Archiv. B, Cell pathology,
R Lugari, and P Dall'Argine, and A Parmeggiani, and A Vattini, and B Dall'Aglio, and G Rignanese, and R Zandomeneghi, and A Gnudi
Human pancreatic polypeptide (HPP) immunoreactivity in an infiltrating endocrine tumour of the papilla of Vater with unusual morphology.
January 1981, Virchows Archiv. A, Pathological anatomy and histology,
Copied contents to your clipboard!